Literature DB >> 3699885

Pathophysiology of experimental leishmaniasis: pattern of development of metastatic disease in the susceptible host.

J O Hill.   

Abstract

A clear understanding of the etiology of the various forms of leishmaniasis will require knowledge of how physiological properties of the parasite and host immunity influence the pattern of development of the disease. Of particular importance are how these factors affect the growth rate of Leishmania spp. at the site of inoculation in the skin, their capacity to disseminate to visceral and distant cutaneous sites, and their capacity to multiply once there. This paper details the pattern of development of disseminated Leishmania major infection in susceptible BALB/c nu/+ and BALB/c nu/nu mice. It was found that the parasite disseminates from the hind footpad to distant cutaneous sites soon after metastatic foci are established in the liver and spleen. Both mononuclear phagocytes and neutrophils may be the vehicles for the transport of the parasite in the blood. Once visceral and cutaneous metastases are established, the parasites in those foci increase in number progressively. L. major has the capacity to multiply at visceral and cutaneous sites at the same rate. Despite the presence of viable parasites in a number of skin sites, cutaneous metastatic lesions developed almost exclusively on the feet and the tail. Furthermore, these lesions appeared to develop preferentially at sites near joints, suggesting that factors other than temperature may influence the development of cutaneous metastatic lesions.

Entities:  

Mesh:

Year:  1986        PMID: 3699885      PMCID: PMC261007          DOI: 10.1128/iai.52.2.364-369.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Current status of the immunology of blood and tissue Protozoa. I. Leishmania.

Authors:  A Zuckerman
Journal:  Exp Parasitol       Date:  1975-12       Impact factor: 2.011

2.  LEISHMANIASIS IN THE SUDAN REPUBLIC. XVIII. PARASITEMIA IN KALA-AZAR.

Authors:  L C ROHRS
Journal:  Am J Trop Med Hyg       Date:  1964-03       Impact factor: 2.345

3.  A model in mice for experimental leishmaniasis with a West African strain of Leishmania tropica.

Authors:  B Bjorvatn; F A Neva
Journal:  Am J Trop Med Hyg       Date:  1979-05       Impact factor: 2.345

4.  Variations in the response of five strains of mice to Leishmania mexicana.

Authors:  H Pérez; F Labrador; J W Torrealba
Journal:  Int J Parasitol       Date:  1979-02       Impact factor: 3.981

5.  The origin and significance of the distribution of parasites in visceral leishmaniasis.

Authors:  L A Stauber
Journal:  Trans N Y Acad Sci       Date:  1966-03

6.  Current concepts in parasitology. Leishmaniasis.

Authors:  P D Marsden
Journal:  N Engl J Med       Date:  1979-02-15       Impact factor: 91.245

7.  Mechanisms of immunity to leishmaniasis. II. Significance of the intramacrophage localization of the parasite.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

8.  Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

Authors:  E Handman; R Ceredig; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1979-02

9.  Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes.

Authors:  R D Pearson; R T Steigbigel
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

10.  Leishmanicidal mechanisms of human polymorphonuclear phagocytes.

Authors:  K P Chang
Journal:  Am J Trop Med Hyg       Date:  1981-03       Impact factor: 2.345

View more
  7 in total

1.  Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.

Authors:  G M Anstead; B Chandrasekar; W Zhao; J Yang; L E Perez; P C Melby
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite.

Authors:  A Hübel; S Krobitsch; A Hörauf; J Clos
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.

Authors:  J O Hill
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

4.  Protective response to Leishmania major in BALB/c mice requires antigen processing in the absence of DM.

Authors:  Tirumalai Kamala; Navreet K Nanda
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

5.  Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.

Authors:  J O Hill; M Awwad; R J North
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

6.  Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection.

Authors:  M Domínguez; A Toraño
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

7.  Polymerase chain reaction detection and inducible nitric-oxide synthase expression of Leishmania major in mice inoculated by two different routes.

Authors:  Abeer E Mahmoud; Rasha Ah Attia; Hanan Em Eldeek; Haiam Mohammed Mahmoud Farrag; Rania Makboul
Journal:  Trop Parasitol       Date:  2016 Jan-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.